- Previous Close
5.60 - Open
5.54 - Bid 3.98 x 100
- Ask 6.87 x 100
- Day's Range
5.33 - 5.59 - 52 Week Range
3.99 - 12.88 - Volume
731,306 - Avg. Volume
1,206,725 - Market Cap (intraday)
242.981M - Beta (5Y Monthly) 1.50
- PE Ratio (TTM)
-- - EPS (TTM)
-0.53 - Earnings Date May 6, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.06
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
lifemd.com304
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: LFMD
View MorePerformance Overview: LFMD
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LFMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LFMD
View MoreValuation Measures
Market Cap
242.98M
Enterprise Value
233.08M
Trailing P/E
--
Forward P/E
24.75
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.06
Price/Book (mrq)
--
Enterprise Value/Revenue
1.10
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.89%
Return on Assets (ttm)
-15.41%
Return on Equity (ttm)
-2,463.00%
Revenue (ttm)
212.45M
Net Income Avi to Common (ttm)
-21.99M
Diluted EPS (ttm)
-0.53
Balance Sheet and Cash Flow
Total Cash (mrq)
35M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
12.32M